Authors: BACKHOUSE ME

Citation: Me. Backhouse, AN INVESTMENT APPRAISAL APPROACH TO CLINICAL-TRIAL DESIGN, Health economics, 7(7), 1998, pp. 605-619

Authors: GRUGER J BACKHOUSE ME

Citation: J. Gruger et Me. Backhouse, ECONOMIC-EVALUATION OF ANTIVIRAL THERAPY FOR THE TREATMENT OF HERPES-ZOSTER IN IMMUNOCOMPETENT ADULTS, PharmacoEconomics, 11(3), 1997, pp. 262-273

Authors: BACKHOUSE ME

Citation: Me. Backhouse, TRAVEL PROPHYLAXIS - JOURNALS SHOULD DEVELOP GUIDELINES FOR ECONOMIC EVALUATIONS, BMJ. British medical journal, 310(6976), 1995, pp. 402-402

Authors: MAUSKOPF JA BACKHOUSE ME JONES D WOLD DE MAMMEL MC MULLETT M GUTHRIE R LONG WA

Citation: Ja. Mauskopf et al., SYNTHETIC SURFACTANT FOR RESCUE TREATMENT OF RESPIRATORY-DISTRESS-SYNDROME IN PREMATURE-INFANTS WEIGHING FROM 700 TO 1350 GRAMS - IMPACT ONHOSPITAL RESOURCE USE AND CHARGES, The Journal of pediatrics, 126(1), 1995, pp. 94-101

Authors: BACKHOUSE ME MAUSKOPF JA JONES D WOLD DE SCHUMACHER R COTTON R LONG WA

Citation: Me. Backhouse et al., ECONOMIC OUTCOMES OF COLFOSCERIL PALMITATE RESCUE THERAPY IN INFANTS WEIGHING 1250G OR MORE WITH RESPIRATORY-DISTRESS SYNDROME - RESULTS FROM A RANDOMIZED TRIAL, PharmacoEconomics, 6(4), 1994, pp. 358-369